FDA Commissioner Discusses Hopes For LDT Legislation

FDA Commissioner Scott Gottlieb spoke at the Brookings Institution March 20 to talk about his departure from the agency. He noted that among the top issues that he hopes will be addressed after he leaves on April 5, are legislation addressing over-the-counter drugs and laboratory developed tests under a in-vitro clinical test bill known as the VALID Act.